Development and Persistence of Antimicrobial Resistance in Pseudomonas aeruginosa : a Longitudinal Observation in Mechanically Ventilated Patients
- 1 April 2007
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (4), 1341-1350
- https://doi.org/10.1128/aac.01278-06
Abstract
Intubated patients frequently become colonized by Pseudomonas aeruginosa , which is subsequently responsible for ventilator-associated pneumonia. This pathogen readily acquires resistance against available antimicrobials. Depending on the resistance mechanism selected for, resistance might either be lost or persist after removal of the selective pressure. We investigated the rapidity of selection, as well as the persistence, of antimicrobial resistance and determined the underlying mechanisms. We selected 109 prospectively collected P. aeruginosa tracheal isolates from two patients based on their prolonged intubation and colonization periods, during which they had received carbapenem, fluoroquinolone (FQ), or combined β-lactam-aminoglycoside therapies. We determined antimicrobial resistance phenotypes by susceptibility testing and used quantitative real-time PCR to measure the expression of resistance determinants. Within 10 days after the initiation of therapy, all treatment regimens selected resistant isolates. Resistance to β-lactam and FQ was correlated with ampC and mexC gene expression levels, respectively, whereas imipenem resistance was attributable to decreased oprD expression. Combined β-lactam-aminoglycoside resistance was associated with the appearance of small-colony variants. Imipenem and FQ resistance persisted for prolonged times once the selecting antimicrobial treatment had been discontinued. In contrast, resistance to β-lactams disappeared rapidly after removal of the selective pressure, to reappear promptly upon renewed exposure. Our results suggest that resistant P. aeruginosa is selected in less than 10 days independently of the antimicrobial class. Different resistance mechanisms lead to the loss or persistence of resistance after the removal of the selecting agent. Even if resistant isolates are not evident upon culture, they may persist in the lung and can be rapidly reselected.Keywords
This publication has 55 references indexed in Scilit:
- Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2006
- Analysis of antibiotic resistance gene expression inPseudomonas aeruginosaby quantitative real-time-PCRFEMS Microbiology Letters, 2006
- Insertional inactivation ofoprD in clinical isolates ofPseudomonas aeruginosaleading to carbapenem resistanceFEMS Microbiology Letters, 2004
- Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistanceFEMS Microbiology Letters, 2004
- Contribution of the MexXY Multidrug Transporter to Aminoglycoside Resistance in Pseudomonas aeruginosa Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Relative expression software tool (REST(C)) for group-wise comparison and statistical analysis of relative expression results in real-time PCRNucleic Acids Research, 2002
- C-Terminal Region of Pseudomonas aeruginosa Outer Membrane Porin OprD Modulates Susceptibility to MeropenemAntimicrobial Agents and Chemotherapy, 2001
- Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed β-lactamase producing strainsJournal of Antimicrobial Chemotherapy, 1990
- Outer membrane proteins of gentamicin induced small colony variants ofPseudomonas aeruginosaFEMS Microbiology Letters, 1989
- Outer membrane proteins of gentamicin induced small colony variants of Pseudomonas aeruginosaFEMS Microbiology Letters, 1989